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ABSTRACT: 
Objective: To describe the experience and acceptability of whole body magnetic resonance 
imaging (WB-MRI) staging compared with standard scans among patients with highly 
suspected or known colorectal or lung cancer. 
Design: Qualitative study using one-to-one interviews with thematic analysis. 
Setting: Patients recruited from 10 hospitals in London, East and South East England 
between March 2013 and July 2014. 
Participants:51 patients (31 male, age range 40 to 89 years), with varying levels of social 
deprivation were recruited consecutively from two parallel clinical trials comparing the 
diagnostic accuracy and cost-effectiveness of WB-MRI with standard scans for staging 
colorectal and lung cancer (‘Streamline- C’ and ‘Streamline-L’). WB-MRI was offered as an 
additional scan as part of the trials. 
Results: In general WB-MRI presented a greater challenge than standard scans, although all 
but 4 patients completed the WB-MRI. Key challenges were: enclosed space, noise and scan 
duration; reduced patient tolerance was associated with claustrophobia, pulmonary symptoms 
and existing co-morbidities.  Coping strategies facilitated scan tolerance and were grouped 
into 1) those intended to help with physical and emotional challenges, and 2) those focused 
on motivation to complete the scan e.g. focusing on health benefit. Our study suggests that 
good staff communication could reduce anxiety and boost coping strategies.  
Conclusions: Although WB-MRI was perceived as more challenging than standard scans, it 
was sufficiently acceptable and tolerated by most patients to potentially replace them if 
appropriate.  
Trial Registration: ISRCTN43958015 and ISRCTN50436483 
Keywords: Cancer Oncology Neoplasms Magnetic Resonance Imaging Patient Satisfaction 
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ARTICLE SUMMARY 
Strengths and limitations of this study 
 This study is the first to describe the experience and acceptability of having a whole 
body MRI in patients with highly suspected lung or colorectal cancer compared with 
standard scans. 
 Qualitative methodology, and large numbers recruited (with wide age range and 
deprivation levels), enabled us to observe that there is a range of intensity of 
difficulties experienced during the whole body MRI. 
 Assessment within the context of a research trial, with some patient declining 
participation due to claustrophobia, might have led to an under-reporting of WB-MRI 
challenge. 
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BACKGROUND  
Current NICE recommended staging pathways for lung and colorectal cancer are often 
complex and time consuming, involving several different imaging tests utilising ionising 
radiation, and potentially adding to the physical and psychological burden of patients with 
suspected cancer (1;2).  For example it is not unusual for a patient with suspected lung cancer 
to undergo diagnostic CT, followed by staging PET-CT, dedicated brain imaging and 
invasive mediastinal nodal sampling prior to the first major treatment decision. More accurate 
and streamlined staging could improve patient outcomes both by triaging to optimal therapy 
and decreasing the time between diagnosis and treatment (3). Whole body magnetic 
resonance imaging (WB-MRI) has been advocated as a safe accurate and efficient “one stop 
shop” investigation that could potentially replace current complex multi-modality staging 
strategies (4).  A single WB-MRI scan could not only accelerate staging but would 
simultaneously reduce exposure to ionising radiation, in theory reducing the risk of 
subsequent radiation induced malignancies, particularly in those diagnosed at a younger age. 
WB-MRI however can be stressful: its duration, 45 to 90 minutes, is longer than standard 
tests - CT takes a few seconds. MRI scanners are noisy and require full body and head 
immersion into a relatively narrow tube, often necessitating coils wrapped around the patient 
that restrict movement. Somewhere between 5-30% of patients experience distress associated 
with the anticipated and actual experience of undergoing MRI (5-9).  Anxiety relates to the 
scan experience itself as well as the result (5). Severe claustrophobia can lead to premature 
scan termination in 1-15% of attempts (10;11), and  distress is associated with elevated post 
scan anxiety (6),  which can engender MRI fear or phobia (12-14), especially problematic in 
patients needing future MRI studies. 
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Increased physical and psychological vulnerability of patients with suspected cancer may 
reduce their ability to cope with a WB-MRI (2;15).  Cancer diagnosis and subsequent 
treatment are still much feared despite recognition of better treatment outcomes (16;17); and 
patients may be experiencing shock, anxiety and worries about the future (15;18). While two 
small qualitative studies have investigated general patient experience of MRI  
(19;20) there have been few descriptions of patients undergoing WB- MRI, particularly in 
those diagnosed with or highly suspected of having cancer.  
 
Patient acceptability is central to the successful adoption of any new technology. Poor 
acceptability could reduce adherence to WB-MRI, which in turn considerably blunts the 
impact of the technology, even if diagnostically superior to existing tests.  
 
Two parallel, multi-centre, prospective cohort studies (21) investigating the diagnostic 
accuracy and cost-effectiveness of WB-MRI compared to standard pathways for newly 
diagnosed lung (‘Streamline-L’) and colon (‘Streamline-C’) cancer have recently completed. 
The aim of this study was to describe patient experience and acceptability of WB-MRI and 
compare with standard staging tests, in the context of lung and colorectal cancer, using 
interviews from patients recruited to the Streamline trials. In the trials, the WB-MRI was 
offered as an additional scan alongside those performed as part of standard care. 
 
METHODS 
There is little existing research describing patients’ experiences of undergoing WB-MRI and 
we adopted a qualitative design as this provides the flexibility to capture rich descriptions of 
experiences without a priori knowledge of potential responses. One-to-one interviews were 
completed face to face (at home or at hospital) or via telephone. Individual interviews were 
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conducted to facilitate expression of emotions and negative experiences that may be inhibited 
in a group setting.  For two interviews a relative was present, to support translation where 
English was not the patient’s first language. Patients were interviewed only once. 
 
Trial and interview study recruitment 
Patients were recruited to the ‘Streamline’ trials from 10 English NHS hospitals and 
consented to undergo WB-MRI in addition to standard staging investigations at one of five 
MRI scan hospital hubs. During trial consent, patients could opt into the interview study and 
were contacted, by psychology researchers by phone, as soon as possible after all imaging 
had been completed. Prior to trial consent patients were given information about cancer 
staging and the WB-MRI; staging was explained to patients as a process where doctors use 
tests to assess whether cancer has spread around the body to help decide best treatment, the 
trial was described as an assessment about whether the WB-MRI may be quicker or better at 
staging newly diagnosed cancer than standard scans. Accelerated treatment pathways meant 
some interviews (n=13) were undertaken after treatment had commenced.  Trial inclusion/ 
exclusion criteria are published (21).  
 
The a priori total sample size was a minimum of 50, stratified by cancer site (25 lung and 25 
colorectal patients). There was flexibility to recruit beyond this number to achieve saturation, 
i.e. the point beyond which further interviews contribute little new information, although this 
was not needed. The first 123 trial patients were approached and 91 (74%) agreed to be 
interviewed.  Of the 91 who agreed,  51 patients (56%) participated; we believed we had 
reached saturation by 50 patients and ceased interviews, however one additional interview 
was subsequently completed as a patient (from the original 91 consenting patients) expressed 
a strong wish to share their views. Reasons patients were not interviewed included: consent 
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retracted (n=8); participation in a related questionnaire study (n=14); withdrawal from the 
main trial (n=12); and interview quota reached before completion of all staging imaging tests 
(n=6). 
 
Conducting the interview  
Interviews were conducted from March 2013 to July 2014, by two female psychology 
researchers (PhD qualified), independent of the clinical trial team, with prior training and 
experience of conducting in-depth interviews with cancer patients(22;23). The researchers 
introduced themselves as working with the doctors at the patient’s hospital and explained that 
the interview was an opportunity to provide feedback about the WB-MRI and other tests the 
patients had had. A topic guide was developed (Box 1) to encourage discussion of key 
aspects of the staging experience including comparisons between WB-MRI and standard 
investigations. This guide was reviewed after completion of the first two interviews to assess 
whether it needed to be modified. Topic ordering and emphasis varied depending on 
relevance to each patient. Open ended questions were followed by verbal probing to elicit 
further clarification.  Interviews lasted between 12 and 86 minutes (mean 48 minutes), and 
were recorded digitally. Participating patients were paid £20 plus travel expenses. 
 
Box 1: Key interview topics 
• I understand that you have been having a number of scans to investigate your 
symptoms, can you tell me what’s been happening? 
• Can you describe what it feels like physically to have the scan? 
• How did you feel during/after/about the test? 
• What were the staff like?  
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• What did you do to cope with [problem identified by patient e.g. noise, keeping 
still, etc] 
• Would you have another WB-MRI if the doctor recommended it? 
 
Additional measures 
Age, gender and postcode data were collated. Postcode was used to calculate an area based 
deprivation score using the 2010 IMD scale (24) which was then categorised into quintiles 
(quintile 1 highest and  quintile 5 lowest deprivation).  
 
Data capture, coding and analysis 
Interviews were transcribed verbatim. NVIVO, version 10, was used to manage data (tagging 
and labelling) while completing thematic analysis (25).  A coding structure was developed by 
(psychology researcher name removed), using transcript review combined with a reflective 
log maintained during interviews, this was reviewed and agreed by both psychology 
researchers. This framework identified themes related to scan events, beliefs, attitudes, and 
emotional responses as well as coping strategies.  Themes identified were influenced by prior 
research as well as emergent from the data. This process was iterative, with constant data 
comparisons to identify similarities and differences within and across individual interviews. 
Matrix tables were created with themes as columns and relevant data summarised into 
separate rows from each transcript. Matrix tables provided an overview of all 51 interviews, 
and ensured that the full range of experiences were represented in the final description. 
Patients were not asked to verify the thematic analysis so as not to increase participation 
burden.   
 
Statistical analysis 
11 
 
Data were entered into SPSS, version 20.  Analysis Of Variance assessed differences in mean 
ages between lung and colorectal patient groups; Chi Square assessed group differences in 
gender, deprivation and interview method; and the Mann-Whitney test was used to assess 
differences in the median time interval from WB-MRI scan to interview date, between patient 
groups.  
 
Ethical review 
The trial protocol was reviewed and ethical permission granted by Camden and Islington 
NRES committee on 03/10/2012 reference numbers: 12/LO/1176 (Streamline C) and 
12/LO/1177 (Streamline L).  
 
 
RESULTS  
Table 1 gives full demographics of the interviewed cohort. All but four patients completed 
the WB-MRI. There were no significant differences in age, gender, or area-based deprivation 
between those who volunteered for interviews (n=91), and those who declined (n=32);  mean 
age: 65 vs. 64, F(1,121) <1, p=0.527; % male: 64% vs. 56%,  X
2 
(df=1, n=123) =0.562, 
p=0.453; % in deprivation categories (Fisher’s Exact Test chi-square: 1.834, p=0.788). 
Similarly there were no significant demographic differences between patients who were 
(n=51) or were not (n=40) interviewed; mean age 65 vs. 64, F (1,89) <1, p=0.579;  gender % 
male: 53.4% vs. 46.6%, X
2 
(df=1, n=91)=0.437, p=0.508,   % in deprivation categories 
(Fisher’s Exact chi-square: 5.247, p=0.254). The majority of patients were interviewed over 
the phone (76%, n=39) and the median interval between WB-MRI and interview was 15 days 
(1-63 days). 
 
Table 1: Demographic characteristics of interview participants, by trial stream 
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 ‘Streamline- L’*  
% (n=25) 
‘Streamline-C’* 
%(n=26) 
Group differences 
Gender    
Male 60 (15) 61.5 (16) X
2
=0.013, df=1, 
p=0.910 Female 40 (10) 38.5 (10) 
    
Mean age (years) 65  
(Sd=11 years) 
64 
(sd=9 years) 
t=0.261, df=49; 
p=0.795 
    
Area Deprivation Score 
(quintile) 
   
Highest   1 52.0 (13) 30.8 (8) X
2
=5.459 
df=2, 
p=0.065 
2 32.0 (8) 23.1 (6) 
Mid to low 3-5 16.0 (4) 46.2 (12) 
I/v method    
Face to Face 20.0 (5) 26.9 (7) X
2
=0.339, df=1; 
p=0.560 Phone 80.0 (20) 73.1 (19) 
    
Median Interval 
between interview and 
WB-MRI 
15 days  
(6-43 days) 
20 days 
 (1-63 days) 
U=270.00, n=51, 
p=0.299 
*Streamline-L’ -lung cancer, ‘Streamline-C’ –colorectal cancer 
 
Was the WB-MRI scan a challenge? Diversity of experience and comparison with other 
scans and tests. 
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As part of the Streamline trials, all patients had WB-MRI as an additional ‘trial’ investigation 
alongside standard staging investigations. For patients recruited to ‘Streamline-C’, standard 
investigation included CT of the chest, abdomen and pelvis, with some undergoing an 
additional abdominal/ pelvic MRI. Patients recruited to ‘Streamline-L’ underwent at least a 
CT and PET-CT with a proportion undergoing bronchoscopy for tissue sampling.  
WB-MRI was perceived to be more challenging than standard scans by many: “I would say 
the most challenging of the MRI scans was the body scan”s56 (60-69, male, Colorectal -‘C’), 
like  “torture - medieval torture”s12 (50-59,male,C) while CT was described as “a walk in 
the park”s42 (60-69, male, C), and “very simple”s35 (50-59, female, Lung – ‘L’).  PET-CT 
was described by some as “so much easier”s51 (70-79, female, L) and “wasn’t so 
unpleasant” s12 (50-59, male, C).  However the CT and PET_CT were not without 
challenges: for example some commented on the intravenous contrast administered during 
the CT scan “you feel a bit, you know, woozy, funny, …and it did make me feel slightly off” 
s63 (<50, male, C) and the perceived ‘invasiveness’ of the radiation exposure associated with 
CT and PET-CT: “all that radiation dye in my system and everything…And it just disturbed 
me. Because I couldn’t go near my niece and she’s only six” s54 (<50, female, L). Another 
patient described the bronchoscopy as more unpleasant “I’d rather have them scans again 
than have that tube down my throat again, that was the worst thing, and I hated it” s73 (60-
69, male, L).  
 
What was difficult about the WB-MRI? 
Factors identified as difficult were: claustrophobia, physical discomfort, noise, scan duration, 
as well as the challenge of coping with emotions elicited during the scan such as fear /panic 
and isolation. There was a range of reaction intensity, with some reporting positive 
experiences (Table 2).  
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Table 2:  Problems and the diversity of challenge experienced related to WB-MRI 
Problem 
No challenge/ 
enjoyable  
Low challenge Medium/ High Did not 
complete 
Enclosed space “I’m not 
claustrophobic
…that 
[enclosed 
space] doesn’t 
frighten me” 
s36 (50-59, 
male, L) 
“Maybe in the 
back of my mind 
you’re worried 
about it [enclosed 
space]” s5(60-69, 
female, C) 
“Coffin came to 
mind…initially, 
you feel like ‘Oh 
god, it’s so close 
in here’” 
s26(60-69, 
female, L) 
“I had this 
sense of being 
in a 
sarcophagus” 
s17(60-69, 
male, L) 
Noise “I thought it 
like music 
really…and it 
relaxed me” 
s64(80+, 
male, C) 
“the noise was a 
bit…disconcertin
g because it was 
quite loud and 
quite sort of 
clanking and 
banging… …and 
it took some time 
getting used to it” 
s63(<50, 
male, C) 
“that's one of the 
worst ones that 
I've had to go 
through with the 
noise… I felt like 
something was 
going to fall off 
and hit me.” 
s54(<50, 
female, L) 
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Scan duration/ 
discomfort 
“It’s actually 
quite 
comfortable in 
there” 
s87(60-69, 
male, L) 
“It was not 
excruciatingly 
painful.  It just 
ached a bit, that 
is all.” 
s18(60-69, 
male, C) 
“My back was 
uncomfortable.  
My, the back of 
my neck was 
uncomfortable…” 
“my brain was 
saying, “You 
can’t go much 
longer… s56(60-
69, male, C) 
 
Negative 
Emotions (e.g. 
anxiety, panic, 
shock, distress) 
 “I mean, there 
wasn’t, you 
know, anything 
in particular to 
be frightening 
[sic]” 
s76(<50, 
male, C) 
“when I first went 
in there, I was 
quite shocked ….  
…I wondered 
what the hell was 
going on… after 
a while I quite 
enjoyed it” 
s18(60-69, 
male, C) 
“when I first laid 
down in the scan 
I was frightened” 
s79(60-69, 
female, C) 
and  “I’m lying 
there and all of a 
sudden, they put 
all these things 
on top of me…    
And I’m thinking, 
‘Oh, my God!  
…this is 
threatening’”s53 
(60-69, male, C) 
I don’t know 
whether the 
people doing 
the scan knew I 
had lung 
cancer, I didn’t 
feel any 
empathy or any 
sort of friendly 
attitude.  I 
walked out of 
there feeling 
quite upset 
actually” s30 
(50-59,male, L) 
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Claustrophobia:  patients described feeling trapped or buried in the WB-MRI “it was the 
feeling of being sort of trapped because you can feel the machine all around your body” s12 
(50-59, male, C) and “I had this sense of being in this sarcophagus” s17 (60-69, male, L). 
Only one participant asked to terminate the scan early because of claustrophobia (s17). In 
comparison the CT scan was described as being like “going through the big polo mint. And, 
therefore, it’s not as much as like entombment” s80 (60-69, male, C) and the PET-CT was 
described as “not as claustrophobic. That one [MRI] is close to your face. And the other one 
[PET-CT] is a bit higher. So that, you know, that’s not a big problem, really” s73 (60-69, 
male, L). 
 
Noise: Noise emitted from the MRI during data acquisition was aversive for some 
“horrendous.  It’s horrible! “s55 (60-69, female, L), but not all, “it was quite good.… I 
would say, ‘What’s coming next?  What’s the next noise?’  So, I enjoyed that” s18 (60-69, 
male, C). The absence of noise was a notable feature of other scans e.g. “PET scan isn’t 
noisy” s91 (60-69, male, L) and “there wasn’t all the noise. That’s the only difference really” 
s41 (60-69, male, L).   
Scan duration and physical discomfort: The scan length differentiated WB-MRI from other 
tests “the CT scan is very quick…you’re in and out.  Whereas, the MRI scan was very long” 
s13 (60-69, female, C). However one patient saw the PET-CT scan duration times as 
equivalent “if you took the PET scan, and take the waiting time [for radioactive glucose to 
circulate], and deduct that, timewise, they’re much the same” s49 (>80, male, L). Duration 
was linked to comfort: “the back of my neck was uncomfortable, [the WB-MRI] maybe 15 
minutes too long to be comfortable” s56 (60-69, male, C). In contrast a patient without 
discomfort viewed the long duration acceptable, “I think it’s over one and a half hour or 
something like that, so it was alright for me… is comfortable” s19 (60-69, male, C).  
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Emotions elicited by WB-MRI: WB-MRI induced strong emotions in some: “I was going to 
have a sort of panic attack and have to be taken out of the machine…this claustrophobia, the 
feeling of being...trapped, really” s12(50-59, male, C). Worry and fear were also prompted 
by the novelty of the experience “the oppression comes from the unknown”s45 (70-79, male, 
C). Dealing with feelings of panic and fear was a challenge in itself and needed effort to 
overcome “when I first laid down in the scan I was frightened…I was trying to put it [fear] 
out of my head and think positively” s79 (60-69, female, C). In comparison “they [CT and 
PET-CT] were slightly more easier to relax in that environment, not that I didn’t relax in the 
MRI scan too, it’s just that it took a bit more sort of power, more energy if you like, to relax” 
s41, (60-69, male, L).   
 
Cancer context: The WB-MRI was perceived to have the potential to either suggest a cancer 
diagnosis or reveal additional findings associated with a poorer prognosis and treatment 
implications “I was lying in there and I was thinking, what if they say it's cancer?  Then, 
what?”  s54 (<50, female, L) and “whether they’d find … it has gone everywhere and you 
know nothing you can do, I suppose that was the main worry” s60 (60-69, female, L). One 
patient had a dilemma whether to go ahead with the scan because of the possibility that its 
findings  might mean he wasn’t offered treatment “I was of two minds about the trial scan 
because I didn’t want the trial scan to say the cancer’s spread and they wouldn’t operate.” 
s30 (50-59, male, L).  However another patient reported relief when the scan confirmed that 
initial tumours were localised “my biggest fear, I know I’ve got the cancer in the bowels.  I’ve 
seen it myself on the colonoscopy.  And I was worried that they might, it might just disguise 
I’ve got other cancers.  So when he said straight away, there was nothing else and I feel 
relieved” s45 (70-79, male, C). There was also appreciation of having the WB-MRI because 
it did reveal spread “The MRI actually showed up even more of what’s going on with me and 
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I think if I hadn’t had it, they would…we still wouldn’t know.  Because they found traces in 
five other places I feel a lot better now having the MRI scan, knowing that they’ve picked up 
on all of it” and “without that, they would…I would just be having the chemo and not the full 
treatment that I need” s25 (<50, female, L).  The existential threat posed by a cancer 
diagnosis may have influenced how physical characteristics of the scan where interpreted, 
one patient described the enclosed experience as being “It's like being in a coffin.  You know, 
I did think that.  It's like being in a coffin.  But I wasn't.  You just have to think that… Because 
if you've got something really, really bad, it would be like being in a coffin.  Just like 
thinking, ‘my God.  This is going to be me’.  You know.  And I would have thought that could 
be quite scary” s16 (60-69, male, C), at this point the patient, recently diagnosed with 
colorectal cancer became tearful. Another patient interpreted MRI sounds to indicate the 
presence of pathology “ And then you’ll hear all these noises coming through you, so you 
wonder…, I thought, if the machine is clicking on, may be something is wrong there with me” 
s13 (60-69, female, C).   
 
Explaining differences in experiences (see Figure One) 
Cancer type: Physical symptoms reported more frequently by those recruited to ‘Streamline-
L’ were associated with discomfort, “I found lying flat on my back, yes, very uncomfortable... 
I was coping okay for about 20, 25 minutes and then that’s when this pressure or aching or 
uncomfortable feeling on my chest began to kick in”s30 (50-59, male, L) and difficulty with  
breath holding “they had to make me do it a few times because I couldn’t hold it for the 
length of time they wanted me to …  I’ve got COPD, whether that made it worse, I don’t 
know" s58 (60-69, male, L).    
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Existing musculoskeletal problems: Sometimes these made the WB-MRI more 
uncomfortable, but not for all: “I do suffer a bit from back pain… My back started to sort of 
be pretty uncomfortable” s42 (60-69, male, C), and “I was worried about my neck being 
uncomfortable … because of arthritis but they managed to sort me out and then I managed to 
last the hour”s18 (60-69, male, C). 
 
Mental health co-morbidities: One patient with prior anxiety found the scan difficult, 
describing their anxiety as causing feelings of claustrophobia “I'm not claustrophobic.  I just 
felt that way because of the anxiety.  When I get anxious, it feels like everything's just closing 
in on me” s54 (<50, female, L).  
 
Prior experiences: One patient terminated the scan because he didn’t like being constrained 
and his aversion came as a surprise, “a sense of being constrained and being strapped down 
which is a new one for me… I haven’t encountered that situation before”s17 (60-69, male, 
L).  In contrast, another participant (s8: 60-69, male, C) who knew he suffered from severe 
claustrophobia requested a sedative and completed the scan with relative ease. Work 
experiences meant some patients were used to confined spaces and/or loud noises, “it doesn't 
bother me.  I've worked in pipes and tunnels and all sorts of places”s91 (60-69, male, L) and 
“if I wasn’t in the trade I suppose that that could really freak you out because it’s quite 
loud…” s76 (<50, male, C). Vicarious experiences were sources of knowledge for patients 
without prior personal experience, and influenced expectations, sometimes reassuring “I have 
a few friends and relatives… they have already done MRI, so I had something from them.  
this [is not] painful or anything like that. ” s19 (60-69, male, C); sometimes contrary to their 
own eventual experience, “it was not as intimidating as I thought… I had heard people 
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talking about going in to an MRI scanner, and they were telling me how nervous they were, 
and how they hated it….  And when I saw it, I thought, ‘That's okay’” s18 (60-69, male, C). 
 
Staff contact: Staff supported patients with verbal reassurance, information provision, as well 
as making them physically comfortable. For example, “they told me all about it so I didn’t get 
anxious. I knew what to expect” s26 (60-69, female, L), and “they managed to find something 
to put under my neck…they did put it in the right place under my neck and I was okay” s18 
(60-69, male, C). Staff communication acted as a distraction “the person speaking keeps my 
mind occupied” s26 (60-69, female, L). Some patients spoke of a sense of isolation when in 
the scanner and hearing a voice confirmed they were not alone “just made me feel a bit 
confident that you wasn’t on your own, you know?” s58 (60-69, female, L). Patients varied in 
whether they felt they received enough information “they told me everything I needed to 
know” s76 (<50, male, C) versus “there wasn’t any [information]…that was the lacking 
part” s35 (50-59, female, L). Whether staff were perceived to be reassuring was also 
important for some and a change in staff mid-way through the scan was detrimental: “she was 
constantly talking to me, I was fine.  But then … another lady took over and she didn’t talk as 
much ...  …when I panicked” s58 (60-69, female, L) and “People I've been speaking with 
beforehand… I've actually built up the initial … trust… Then, suddenly, a complete stranger 
is now telling me to breathe in and out… then said, ‘ I should be coming down now to inject 
you with dye’… “In my mind, I thought the absolutely bizarre” s80 (60-69, male, C). Failure 
to heed a patient preference influenced their decision to terminate the scan “…they told me 
that they were going to inject dye. And once again I said ‘don’t put that cannula in my left 
arm’ but she did and the vein collapsed. And I said to them ‘I can’t do any more now… I’ve 
had enough’” s30 (50-59, Male, L). 
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Coping: Patients adopted various coping strategies, categorised into two main groups: 1) 
strategies for coping with distressing thoughts, emotional responses, or physical sensations, 
e.g. mental distraction and relaxation. “Because I love Cyprus I was thinking of Cyprus the 
whole time.  And it sort of takes your mind off of what’s going”s55 (60-69, female, L) and 
“breathing, breathing…And you know trying to sort of just to calm…Because you can’t help 
but get anxious”s60 (60-69, female, L); and 2) Strategies related to motivation to complete 
the scan, such as focusing on benefit beliefs: “I was so fed up with pain that I would have 
done…you know, any investigation was better… it was [WB-MRI] something to get me 
better"s14 (60-69, female, C). “I was laying there and I was thinking, ‘Well, it’s for my own 
benefit so I can live with that’”s8 (60-69, male, C) and “knowing I had cancer, you know, 
that's probably the most frightening thing that probably anyone could be told…  So, this 
[WB_MRI]was all a culmination of things that's going to help me get better….The bed 
rocking a little bit, these loud noises really palled into insignificance because in my body 
now, I've got a nasty little house guest, which has now stayed, not welcome.  I'm going to rid.  
And this is part of the mechanism to get rid…I was totally focused on the cancer.  And these 
are the pictures that would help me get that done” s80 (60-69, male, C). 
Patients undergoing the WB-MRI scan were not only faced with the challenge of a potentially 
new technology, but were also coping with a possible or recent cancer diagnosis. For some, 
this influenced the challenge posed by the WB-MRI; “it’s been you know really anxious time.  
It’s not just going to have an MRI.  You obviously know something is wrong with and you’re 
hoping that there’s only going to be one thing wrong with you and then you get two things 
[tests prior to WB-MRI found a spine tumour in addition to lung cancer].  And all of a 
sudden, it’s a completely different ballgame you know for me.  About that stage, I had 
realised that I probably wasn’t going to be able have the operation and just carry on with my 
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life as normal.   …. which is why I was finding it so hard to relax.  It wasn’t the MRI, it was 
just me.  …you’re stressed out” s60 (60-69, female, L). 
 
Willingness to have another WB-MRI Scan  
All patients stated they would undergo another WB-MRI scan if the doctor recommended it, 
including the four patients who had requested scan termination. However this agreement was 
offered with varying enthusiasm; “well if I have to….I don’t like it one bit but if it has to be 
done” s73 (60-69, male, L) compared with “yes without hesitation” s63(<50,male,C).   
 
CONCLUSIONS 
We aimed to describe patient experience and acceptability of WB- MRI as a potential 
replacement for the modalities currently used for staging lung and colorectal cancer. Patients 
recognised that WB-MRI was different from other scans although the extent of the challenge 
varied considerably. The majority completed WB-MRI with just four patients requesting 
premature termination; all were prepared to attempt future WB-MRI. Patients adopted a 
variety of coping strategies, these centred on the physical and emotional responses 
experienced during scanning, as well as focusing on beliefs that bolstered motivation to 
complete the scan.  
 
To our knowledge, there are only two other comparable qualitative studies of patients’ 
experiences of MRI (19;20). In common with our study the enclosed space, noise, physical 
discomfort and duration were identified as challenging, and the need for staff support was 
also highlighted.  The importance of a “trustful dialogue” between radiographer and patients, 
to facilitate coping strategies (19), resonate with comments made by patients in our study.  
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Noise and confinement are the most frequently cited negative aspects of MRI in quantitative 
work published over the last 20 years (6;12). Other studies identify additional factors 
increasing the likelihood of premature scan termination, including acquisition position (head 
first, and/or prone); age and gender (middle age or female); prior experience (first scan or 
prior negative experience) and comorbidity (pain, anxiety) (6;13;26;27).   Our results concur 
with some of these findings; we found some evidence that co-morbidity (e.g. anxiety and 
physical symptoms) increased scan challenge although there were contrary examples where 
musculoskeletal patients did not experience anticipated discomfort after adjustments were 
made by staff.  Unlike others studies (e.g. (12;14)) prior experience (positive or negative) 
generally increased coping ability. 
 
Our study adds to the existing literature. Our patient cohort were highly suspected or just 
diagnosed with cancer, and we were able to elicit influences of this on their experience of 
MRI. Furthermore the specific scan type under investigation (WB MRI) differs from simpler 
MRI scans such as knees and spine, based on its longer duration and need for receiver coils to 
cover the whole body. Patients described how the WB-MRI had the potential to reveal a 
cancer diagnosis or additional metastatic disease, with treatment implications. This caused 
anxiety and a dilemma as to whether to have the scan. However some patients also described 
relief and gratitude for having the scan either when it found no additional cancer or indeed 
when it diagnosed additional metastatic disease.  The perceived length of the scan, together 
with its title of “whole body” may have added to patients perceptions about its ability to 
influence their treatment and prognosis.   The WB-MRI scanner was likened to a coffin or 
sarcophagus and it is possible that these observations were more emotive because the patients 
were contemplating a life threatening diagnosis. Carlsson and Carlsson (19) reported greater 
fear when MRI was used to confirm serious illness. WB-MRI for cancer staging comes at a 
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point when patients are likely to be emotionally vulnerable, stretching coping resources for 
challenging medical procedures. However, while the implications of scanning patients with 
co-morbidities and emotional vulnerability should be acknowledged, it is important to note 
that most completed the WB-MRI.  
 
Our study suggests that good staff communication could reduce anxiety and boost coping 
strategies by acting as a source of distraction, motivation and emotional reassurance.  The 
varied experiences encountered underline the need for staff interaction to be tailored. 
Advanced staff training to build rapport can reduce MRI non-completion rates and increase 
patient satisfaction (28;29).  A recent UK survey suggests that whilst strategies are in place to 
help reduce MRI related anxiety (commonly written leaflets, verbal pre-scan information, 
music during scanning, dedicated staff support), these are not optimised yet, with resource 
restrictions a potential barrier to implementation (30).  
 
Study limitations 
The generalisability of our results may be limited. WB-MRI was performed within the 
context of a research trial and some patients declined participation citing claustrophobia. 
Acceptability of WB-MRI may be lower than our study suggests. However the patients were 
from a wide age range and deprivation levels, and were interviewed from a number of 
different hospitals. As a result, a diverse spread of experiences were documented and 
included some who ultimately were unable to tolerate scanning.  
 
Clinical implications 
Our study confirms that WB-MRI can be a challenging experience and that staff support is 
important in modifying scan related stress. Our study also highlights that patient experience is 
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varied and for the most part, the scan was tolerated, suggesting WB-MRI could potentially 
replace existing modalities, assuming adequate diagnostic accuracy and cost-effectiveness. 
Experience of WB-MRI reflects the success of coping strategies adopted by patients and the 
quality of support they receive. Further research would facilitate understanding of the 
interrelationship between patients’ experiences, the effectiveness of their coping strategies, 
and of the support received from staff such that patients and clinicians can benefit maximally 
from the diagnostic potential of WB-MRI.  
 
Figure One: A model illustrating the factors that influence a patient’s WB-MRI experience. 
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